516 related articles for article (PubMed ID: 19359219)
1. Vaccinating with the genome: a Sisyphean task?
Coppel RL
Trends Parasitol; 2009 May; 25(5):205-12. PubMed ID: 19359219
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
3. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
Ballou WR; Kester KE; Heppner DG
Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
[No Abstract] [Full Text] [Related]
4. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
Saul A
J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
[No Abstract] [Full Text] [Related]
5. Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.
Cowman AF; Baldi DL; Duraisingh M; Healer J; Mills KE; O'Donnell RA; Thompson J; Triglia T; Wickham ME; Crabb BS
Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):25-33. PubMed ID: 11839179
[TBL] [Abstract][Full Text] [Related]
6. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
Sutherland CJ
Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726
[TBL] [Abstract][Full Text] [Related]
7. Strain-specific humoral response to a polymorphic malaria vaccine.
Flück C; Smith T; Beck HP; Irion A; Betuela I; Alpers MP; Anders R; Saul A; Genton B; Felger I
Infect Immun; 2004 Nov; 72(11):6300-5. PubMed ID: 15501757
[TBL] [Abstract][Full Text] [Related]
8. Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.
Bermúdez A; Reyes C; Guzmán F; Vanegas M; Rosas J; Amador R; Rodríguez R; Patarroyo MA; Patarroyo ME
Vaccine; 2007 May; 25(22):4487-501. PubMed ID: 17403557
[TBL] [Abstract][Full Text] [Related]
9. The case for a subunit vaccine against malaria.
Anders RF
Trends Parasitol; 2011 Aug; 27(8):330-4. PubMed ID: 21592861
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites.
Zhang D; Pan W
Infect Immun; 2005 Oct; 73(10):6530-6. PubMed ID: 16177327
[TBL] [Abstract][Full Text] [Related]
11. A malaria vaccine based on a sporozoite antigen.
Nussenzweig RS; Zavala F
N Engl J Med; 1997 Jan; 336(2):128-30. PubMed ID: 8988893
[No Abstract] [Full Text] [Related]
12. Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein.
Moorthy SA; Yasawardena SG; Ramasamy R
Vaccine; 2009 Aug; 27(36):4947-52. PubMed ID: 19545652
[TBL] [Abstract][Full Text] [Related]
13. Malaria: new vaccines for old?
Waters A
Cell; 2006 Feb; 124(4):689-93. PubMed ID: 16497579
[TBL] [Abstract][Full Text] [Related]
14. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
[TBL] [Abstract][Full Text] [Related]
16. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
[TBL] [Abstract][Full Text] [Related]
17. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria.
Polley SD; Mwangi T; Kocken CH; Thomas AW; Dutta S; Lanar DE; Remarque E; Ross A; Williams TN; Mwambingu G; Lowe B; Conway DJ; Marsh K
Vaccine; 2004 Dec; 23(5):718-28. PubMed ID: 15542195
[TBL] [Abstract][Full Text] [Related]
18. The hope but challenge for developing a vaccine that might control malaria.
Good MF
Eur J Immunol; 2009 Apr; 39(4):939-43. PubMed ID: 19350585
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate.
Palacpac NM; Arisue N; Tougan T; Ishii KJ; Horii T
Vaccine; 2011 Aug; 29(35):5837-45. PubMed ID: 21718740
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity and natural selection at the domain I of apical membrane antigen-1 (AMA-1) of Plasmodium falciparum in isolates from Iran.
Mardani A; Keshavarz H; Heidari A; Hajjaran H; Raeisi A; Khorramizadeh MR
Exp Parasitol; 2012 Apr; 130(4):456-62. PubMed ID: 22306282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
